Wu FY - Search Results

1

Differences in Immunological Landscape between EGFR-Mutated and Wild-Type Lung Adenocarcinoma.

Luo JW, Guo YH, Wu FY, Li XF, Sun XC, Wang JL, Zhou CC. Luo JW, et al. Among authors: wu fy. Dis Markers. 2021 Aug 26;2021:3776854. doi: 10.1155/2021/3776854. eCollection 2021. Dis Markers. 2021. PMID: 34484468 Free PMC article.

2

Hyperpigmentation in palms associated with lung adenocarcinoma resolving after chemotherapy.

Wu F, Su C, Liu L, Xu J. Wu F, et al. Clin Respir J. 2016 May;10(3):368-70. doi: 10.1111/crj.12226. Epub 2014 Nov 26. Clin Respir J. 2016. PMID: 25425269

3

Feasibility of cytological specimens for ALK fusion detection in patients with advanced NSCLC using the method of RT-PCR.

Wang Y, Liu Y, Zhao C, Li X, Wu C, Hou L, Zhang S, Jiang T, Chen X, Su C, Gao G, Li W, Wu F, Li A, Ren S, Zhou C, Zhang J. Wang Y, et al. Lung Cancer. 2016 Apr;94:28-34. doi: 10.1016/j.lungcan.2016.01.014. Epub 2016 Jan 25. Lung Cancer. 2016. PMID: 26973203

4

The role of endobronchial ultrasound elastography in the diagnosis of mediastinal and hilar lymph nodes.

Gu Y, Shi H, Su C, Chen X, Zhang S, Li W, Wu F, Gao G, Wang H, Chu H, Zhou C, Zhou F, Ren S. Gu Y, et al. Oncotarget. 2017 Jul 6;8(51):89194-89202. doi: 10.18632/oncotarget.19031. eCollection 2017 Oct 24. Oncotarget. 2017. PMID: 29179511 Free PMC article.

5

Mutational Landscape of cfDNA Identifies Distinct Molecular Features Associated With Therapeutic Response to First-Line Platinum-Based Doublet Chemotherapy in Patients with Advanced NSCLC.

Jiang T, Li X, Wang J, Su C, Han W, Zhao C, Wu F, Gao G, Li W, Chen X, Li J, Zhou F, Zhao J, Cai W, Zhang H, Du B, Zhang J, Ren S, Zhou C, Yu H, Hirsch FR. Jiang T, et al. Theranostics. 2017 Oct 17;7(19):4753-4762. doi: 10.7150/thno.21687. eCollection 2017. Theranostics. 2017. PMID: 29187901 Free PMC article. Clinical Trial.

6

Successful treatment using apatinib with or without docetaxel in heavily pretreated advanced non-squamous non-small cell lung cancer: A case report and literature review.

Wu F, Zhang S, Gao G, Zhao J, Ren S, Zhou C. Wu F, et al. Cancer Biol Ther. 2018 Mar 4;19(3):141-144. doi: 10.1080/15384047.2017.1414757. Epub 2018 Jan 15. Cancer Biol Ther. 2018. PMID: 29261000 Free PMC article. Review.

7

Characterization of never-smoking and its association with clinical outcomes in Chinese patients with small-cell lung cancer.

Liu X, Jiang T, Li W, Li X, Zhao C, Shi J, Zhao S, Jia Y, Qiao M, Zhang L, Luo J, Gao G, Zhou F, Wu F, Chen X, He Y, Ren S, Su C, Zhou C. Liu X, et al. Lung Cancer. 2018 Jan;115:109-115. doi: 10.1016/j.lungcan.2017.11.022. Epub 2017 Nov 26. Lung Cancer. 2018. PMID: 29290250

8

Distinct clinicopathologic features, genomic characteristics and survival of central and peripheral pulmonary large cell neuroendocrine carcinoma: From different origin cells?

Zhou F, Hou L, Ding T, Song Q, Chen X, Su C, Li W, Gao G, Ren S, Wu F, Fan J, Wu C, Zhang J, Zhou C. Zhou F, et al. Lung Cancer. 2018 Feb;116:30-37. doi: 10.1016/j.lungcan.2017.12.009. Epub 2017 Dec 15. Lung Cancer. 2018. PMID: 29413048

9

Comprehensive evaluation of NT5E/CD73 expression and its prognostic significance in distinct types of cancers.

Jiang T, Xu X, Qiao M, Li X, Zhao C, Zhou F, Gao G, Wu F, Chen X, Su C, Ren S, Zhai C, Zhou C. Jiang T, et al. BMC Cancer. 2018 Mar 7;18(1):267. doi: 10.1186/s12885-018-4073-7. BMC Cancer. 2018. PMID: 29514610 Free PMC article.

10

Outcomes of Pemetrexed-based chemotherapies in HER2-mutant lung cancers.

Wang Y, Zhang S, Wu F, Zhao J, Li X, Zhao C, Ren S, Zhou C. Wang Y, et al. BMC Cancer. 2018 Mar 27;18(1):326. doi: 10.1186/s12885-018-4277-x. BMC Cancer. 2018. PMID: 29587667 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

529 results

Search Page

Filters